Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 10:17 PM
Ignite Modification Date:
2025-12-25 @ 7:51 PM
NCT ID:
NCT01973335
Group ID:
EG002
Title:
Acetazolamide/Low-dose Loop Diuretics, no Spironolactone
Description:
* Patients receive 500 mg of intravenous acetazolamide immediately after randomization, with 250 mg intravenous acetazolamide administered on each consecutive day in the morning for as long as the patient is considered volume overloaded by his/her treating cardiologist.
* Patients receive 2 mg of intravenous bumetanide immediately after randomization, with 1 mg intravenous bumetanide administered on each consecutive day in the morning for as long as the patient is considered volume overloaded by his/her treating cardiologist.
* Spironolactone use is prohibited during the first 72 h, but encouraged at discharge.
Deaths Number Affected:
5
Deaths Number At Risk:
None
Serious Number Affected:
2
Serious Number At Risk:
9
Other Number Affected:
7
Other Number At Risk:
9
Study:
NCT01973335
Results Section:
NCT01973335
Adverse Events Module:
NCT01973335